Dr. Preeti Malani, Chief Health Officer & Professor of Medicine in the Division of Infectious Diseases, University of Michigan, says that vaccinating a large number of people in areas of exposure risk are among the keys in determining effectiveness of a COVID-19 vaccine, whereas areas of less exposure will not see a difference in effectiveness between the vaccine and placebo recipients if a trial is performed in a less COVID-risky population.
Stay up to date with our videos by subscribing to our channel: https://www.youtube.com/user/CivicCenterTV15?sub_confirmation=1.
Visit our website for more information on the Megacast and Coronavirus: https://civiccentertv.com/
Follow us ⬇ ⬇
• https://www.youtube.com/user/CivicCenterTV15
• https://www.facebook.com/civiccentertv15/
• https://twitter.com/CivicCenterTV
• https://www.instagram.com/civiccentertv/